1253764

GSK LLC (GlaxoSmithKline) — FEI 3006810568

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 22, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Collegeville, PA (United States)

Additional Details

Sponsor, Contract Research Organization